SAHPRA & Egyptian Drug Authority Forge New...

By Staff Writer

July 13, 2023

Exciting news from Pretoria! The South Africa Health Products Regulatory Authority (SAHPRA) has inked a groundbreaking Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA). This monumental allian...
Strengthening Global Health Economics through BRICS Health & Pharmaceuti...
New treatment option for active lupus nephritis!
The updated Medscheme specialised drug list for 2023 has been published
Equity in Global Health Research: Lessons from the 8Quity Tool
Addressing Concerns for Successful Implementation of National Health Insuranc...
WHO Identifies Emerging Innovations in Global Health
Political Economy Analysis Reveals Challenges Facing Primary Health Care in E...
ICER, CADTH, and NICE collaborate to increase transparency in health technolo...
Prioritizing Mental Health in South African Medical Schemes: Challenges and O...
ICER Report on Lecanemab: Efficacy, Cost, and Equity Concerns for Alzheimer&#...
New Preferred Characteristics for Monoclonal Antibodies in Malaria Prevention
Tezepelumab as an Add-on Maintenance Treatment for Severe Asthma: Recommendat...